SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-584833
Filing Date
2016-05-10
Accepted
2016-05-10 09:01:35
Documents
50
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d176184d10q.htm 10-Q 546387
2 EX-31.1 d176184dex311.htm EX-31.1 7424
3 EX-31.2 d176184dex312.htm EX-31.2 7404
4 EX-32.1 d176184dex321.htm EX-32.1 4988
  Complete submission text file 0001193125-16-584833.txt   2557972

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aqxp-20160331.xml EX-101.INS 393604
6 XBRL TAXONOMY EXTENSION SCHEMA aqxp-20160331.xsd EX-101.SCH 30363
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqxp-20160331_cal.xml EX-101.CAL 40430
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqxp-20160331_def.xml EX-101.DEF 96104
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqxp-20160331_lab.xml EX-101.LAB 258161
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqxp-20160331_pre.xml EX-101.PRE 180836
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 161633886
SIC: 2834 Pharmaceutical Preparations